REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
Tuberville, Tommy
R-ALsenate
- Reported action
- Purchase
- Disclosed amount range
- $1,001 - $15,000
- Transaction date
- Apr 3, 2023
- Filing date
- May 12, 2023
- Reported owner
- joint
- Filing timeliness
- On time
Committee oversight: Chairman, Senate Committee on Health, Education, Labor, and Pensions - Education and the American Family (Drug pricing, health insurance, biotech)
Amounts are disclosed ranges, not exact transaction values. Senate coverage is complete; House coverage is partial.
Read the original government filing ↗